Cover Image

Deciphering the molecular mechanism of tetrandrine in inhibiting hepatocellular carcinoma and increasing sorafenib sensitivity by combining network pharmacology and experimental evaluation

Context The mechanism of tetrandrine (TET) in hepatocellular carcinoma (HCC) progression and sorafenib (Sora) chemosensitivity deserves investigation. Objective Using network pharmacology approaches to elucidate the mechanisms of TET in HCC. Materials and methods CCK-8, colony formation, and flow cy...

Full description

Saved in:

Bibliographic Details
Main Authors:	Biao Niu (Author), Sidong Wei (Author), Jianjun Sun (Author), Huibo Zhao (Author), Bing Wang (Author), Guoyong Chen (Author)
Format:	Book
Published:	Taylor & Francis Group, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma
by: Yingru Zhi, et al.
Published: (2019)

Mechanism of Tetrandrine Against Endometrial Cancer Based on Network Pharmacology
by: Shang W, et al.
Published: (2021)

Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Astragalus–Atractylodes Herb Pair in Treating Hepatocellular Carcinoma
by: Liang Y, et al.
Published: (2024)

Network pharmacology based investigation on the mechanism of tetrandrine against breast cancer
by: Bhagya N
Published: (2023)

Integrating Network Pharmacology and Pharmacological Evaluation for Deciphering the Action Mechanism of Herbal Formula Zuojin Pill in Suppressing Hepatocellular Carcinoma
by: Wei Guo, et al.
Published: (2019)

Progress on structural modification of Tetrandrine with wide range of pharmacological activities
by: Liuying Mo, et al.
Published: (2022)

Deciphering the Mechanism of Xijiao Dihuang Decoction in Treating Psoriasis by Network Pharmacology and Experimental Validation
by: Guo Y, et al.
Published: (2023)

Kaempferol-Mediated Sensitization Enhances Chemotherapeutic Efficacy of Sorafenib Against Hepatocellular Carcinoma: An In Silico and In Vitro Approach
by: Bhagyalakshmi Nair, et al.
Published: (2020)

Molecular mechanism of Ganji Fang in the treatment of hepatocellular carcinoma based on network pharmacology, molecular docking and experimental verification technology
by: Miaolun Yang, et al.
Published: (2023)

Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma
by: Can G. Leineweber, et al.
Published: (2023)

Integrating network pharmacology and experimental validation to decipher the mechanism of the Chinese herbal prescription modified Shen-Yan-Fang-Shuai formula in treating diabetic nephropathy
by: Borui Yu, et al.
Published: (2023)

Deciphering the action mechanism of paeoniflorin in suppressing pancreatic cancer: A network pharmacology study and experimental validation
by: Chunhao Cao, et al.
Published: (2022)

Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Huanglian Jiedu Decoction in Treating Atherosclerosis
by: Liang J, et al.
Published: (2021)

Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma
by: Can G. Leineweber, et al.
Published: (2024)

Integrating network pharmacology, bioinformatics, and experimental validation to unveil the molecular targets and mechanisms of galangin for treating hepatocellular carcinoma
by: Xiaoliang Li, et al.
Published: (2024)

Synthesis and anti-hepatocellular carcinoma activity of aminopyridinol-sorafenib hybrids
by: Bhuwan Prasad Awasthi, et al.
Published: (2021)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
by: Koen G. A. M. Hussaarts, et al.
Published: (2021)

The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk
by: Chang Xu, et al.
Published: (2024)

Deciphering the Pharmacological Mechanisms of Ma Xing Shi Gan Decoction against COVID-19 through Integrating Network Pharmacology and Experimental Exploration
by: Qianqian Li, et al.
Published: (2020)

A network pharmacology-based strategy deciphers the underlying molecular mechanisms of Qixuehe Capsule in the treatment of menstrual disorders
by: Yanqiong Zhang, et al.
Published: (2017)

Exacerbation of psoriasis with pustulation by sorafenib in a patient with metastatic hepatocellular carcinoma
by: Takenobu Ohashi, et al.
Published: (2019)

Atypical targetoid eruption induced by sorafenib in a patient with hepatocellular carcinoma
by: Pinar Incel Uysal, et al.
Published: (2020)

Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights
by: Xinchen Tian, et al.
Published: (2022)

Deciphering the Pharmacological Mechanisms of Taohe-Chengqi Decoction Extract Against Renal Fibrosis Through Integrating Network Pharmacology and Experimental Validation In Vitro and In Vivo
by: Shanshan Zhou, et al.
Published: (2020)

Deciphering the Pharmacological Mechanisms of Guizhi-Fuling Capsule on Primary Dysmenorrhea Through Network Pharmacology
by: Siqin Zhang, et al.
Published: (2021)

Integrating Network Pharmacology and Molecular Docking Approaches to Decipher the Multi-Target Pharmacological Mechanism of <i>Abrus precatorius</i> L. Acting on Diabetes
by: Fatima Noor, et al.
Published: (2022)

Deciphering the underlying mechanism of Xianlinggubao capsule against osteoporosis by network pharmacology
by: Hangsheng Bao, et al.
Published: (2020)

Interpreting the Pharmacological Mechanisms of Huachansu Capsules on Hepatocellular Carcinoma Through Combining Network Pharmacology and Experimental Evaluation
by: Jihan Huang, et al.
Published: (2020)

Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
by: Liu KC, et al.
Published: (2020)

Synthesis, characterization, and antiproliferative evaluation of novel sorafenib analogs for the treatment of hepatocellular carcinoma
by: Marwan Imad Jihad, et al.
Published: (2023)

Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways
by: Haofeng Lu, et al.
Published: (2022)

Deciphering the Underlying Mechanisms of Formula Le-Cao-Shi Against Liver Injuries by Integrating Network Pharmacology, Metabonomics, and Experimental Validation
by: Qing Zhao, et al.
Published: (2022)

A Novel Aurora-A Inhibitor (MLN8237) Synergistically Enhances the Antitumor Activity of Sorafenib in Hepatocellular Carcinoma
by: Kai Zhang, et al.
Published: (2018)

Deciphering the Pharmacological Mechanisms of the Huayu-Qiangshen-Tongbi Formula Through Integrating Network Pharmacology and In Vitro Pharmacological Investigation
by: Zihao Wang, et al.
Published: (2019)

An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification
by: Shan Lu, et al.
Published: (2022)

Investigations of nitazoxanide molecular targets and pathways for the treatment of hepatocellular carcinoma using network pharmacology and molecular docking
by: Shakeel Ahmad Khan, et al.
Published: (2022)

Mechanisms of dihydromyricetin against hepatocellular carcinoma elucidated by network pharmacology combined with experimental validation
by: Shuo Zhang, et al.
Published: (2023)

Deciphering the pharmacological mechanisms of Fraxini Cortex for ulcerative colitis treatment based on network pharmacology and in vivo studies
by: Tianming Wang, et al.
Published: (2023)

Pharmacokinetically guided dosing of oral sorafenib in pediatric hepatocellular carcinoma: A simulation study
by: John C. Panetta, et al.
Published: (2021)

Inhibition of the PINK1-Parkin Pathway Enhances the Lethality of Sorafenib and Regorafenib in Hepatocellular Carcinoma
by: Shun Zhang, et al.
Published: (2022)